Female collegiate athletes with serum relaxin concentrations above 6.0 pg/mL have been shown to have more than 4 times increased risk for anterior cruciate ligament (ACL) tears. However, the intracellular effect of relaxin on ACL cells has not been elucidated.
Hypotheses:
The hypotheses were that relaxin binding to receptors on female ACL cells will result in (1) an increase in matrix metalloproteinase (MMP) and decrease in tissue inhibitor of metalloproteinase (TIMP) gene expression, (2) a decrease in collagen and alpha smooth muscle actin (αSMA) expression, (3) inhibition of transforming growth factor β1 (TGFβ1)–induced fibrosis, and (4) an increase in cyclic adenosine 3′,5′-monophosphate (cAMP) production and that these changes will not be observed in male ACL cells.
Study Design:
Controlled laboratory study.
Methods:
Ligament cells from ACL tissue were isolated from 7 male and 7 female human donors and expanded in vitro. The cells were incubated with escalating concentrations of relaxin-2, as well as with TGFβ1 or 17β-estradiol in certain groups. Cells were then lysed and analyzed for MMP1 (collagenase-1), MMP3 (stromelysin-1), MMP13 (collagenase-3), TIMP1, type I collagen, type III collagen, and/or αSMA mRNA expression using quantitative real-time polymerase chain reaction. Intracellular cAMP levels were assessed via an enzyme-linked immunoassay.
Results:
ACL cells primed with estrogen and treated with 10 ng/mL and 100 ng/mL relaxin illustrated increased MMP1 expression (P = .012 and .006, respectively) and MMP3 expression (P = .005 and .001, respectively). Treatment with 100 ng/mL relaxin decreased αSMA expression (P = .001). When ACL tissue isolated from female donors with a history of oral contraceptive use was excluded from the analysis, 100 ng/mL of relaxin decreased type I collagen (P = .005) and type III collagen (P = .028) expression in cells primed with estrogen. Relaxin exhibited no significant effect on male-derived ACL cells.
Conclusion:
Relaxin-2 significantly upregulated intracellular processes in human female ACL cells, but no effect was observed in male cells. Relaxin increased MMP (MMP1 and MMP3) and decreased αSMA and type I and III collagen expression, which may act to alter the structural integrity of the ACL tissue over time.
Clinical Relevance:
Female athletes with higher circulating relaxin levels may be more susceptible to ACL injury.
AhmadNWangWNairRKapilaS. Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ξ pathways. Mol Cell Endocrinol. 2012;363(1-2):46-61.
2.
ArendtEDickR. Knee injury patterns among men and women in collegiate basketball and soccer: NCAA data and review of literature. Am J Sports Med. 1993;23(6):694-701.
3.
BathgateRAHallsMLVan Der WesthuizenETCallanderGEKocanMSummersRJ. Relaxin family peptides and their receptors. Physiol Rev. 2013;93(1):405-480.
4.
BathgateRAIvellRSanbornBMSherwoodODSummersRJ. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev. 2006;58(1):7-31.
5.
BennettRGKharbandaKKTumaDJ. Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. Biochem Pharmacol. 2003;66(5):867-874.
6.
BissonLJGurske-DePerioJ. Axial and sagittal knee geometry as a risk factor for noncontact anterior cruciate ligament tear: a case-control study. Arthroscopy. 2010;26(7):901-906.
7.
CherngSYoungJMaH. Alpha-smooth muscle actin (α-SMA). J Am Sci. 2008;4(4):7-9.
8.
DehghanFHaerianBSMuniandySYusofADragooJLSallehN. The effect of relaxin on the musculoskeletal system. Scand J Med Sci Sports. 2014;24(4):e220-e229.
9.
DiczfalusyE. Mode of action of contraceptive drugs. Am J Obstet Gynecol. 1968;100(1):136-162.
10.
DragooJLCastilloTNBraunHJRidleyBAKennedyACGolishSR. Prospective correlation between serum relaxin concentration and anterior cruciate ligament tears among elite collegiate female athletes. Am J Sports Med. 2011;39(10):2175-2180.
11.
DragooJLLeeRSBenhaimPFinermanGMHameSL. Relaxin receptors in the human female anterior cruciate ligament. Am J Sports Med. 2003;31(4):577-584.
12.
DragooJLPadrezKWorkmanRLindseyDP. The effect of relaxin on the female anterior cruciate ligament: analysis of mechanical properties in an animal model. Knee. 2009;16(1):69-72.
13.
DuthonVBBareaCAbrassartSFaselJHFritschyDMénétreyJ. Anatomy of the anterior cruciate ligament. Knee Surg Sports Traumatol Arthrosc. 2006;14(3):204-213.
14.
FaryniarzDABhargavaMLajamCAttiaETHannafinJA. Quantitation of estrogen receptors and relaxin binding in human anterior cruciate ligament fibroblasts. In Vitro Cell Dev Biol Anim. 2006;42(7):176-181.
15.
GilchristJMandelbaumBRMelanconH. A randomized controlled trial to prevent noncontact anterior cruciate ligament injury in female collegiate soccer players. Am J Sports Med. 2008;36(8):1476-1483.
16.
GriffinLYAgelJAlbohmMJ. Noncontact anterior cruciate ligament injuries: risk factors and prevention strategies. J Am Acad Orthop Surg. 2001;8(3):141-150.
17.
GwinnDEWilckensJHMcDevittERRossGKaoTC. The relative incidence of anterior cruciate ligament injury in men and women at the United States Naval Academy. Am J Sports Med. 2000;28(1):98-102.
18.
HallsMLHewitsonTDMooreXLDuXJBathgateRASummersRJ. Relaxin activates multiple cAMP signaling pathway profiles in different target cells. Ann N Y Acad Sci. 2009;1160:108-111.
19.
HashemGZhangQHayamiTChenJWangWKapilaS. Relaxin and β-estradiol modulate targeted matrix degradation in specific synovial joint fibrocartilages: progesterone prevents matrix loss. Arthritis Res Ther. 2006;8(4):R98.
20.
HeegMHKoziolekMJVaskoR. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int. 2004;68(1):96-109.
21.
HeitzNAEisenmanPABeckCLWalkerJA. Hormonal changes throughout the menstrual cycle and increased anterior cruciate ligament laxity in females. J Athl Train. 1999;34(2):144-149.
22.
HewettTELindenfeldTNRiccobeneJVNoyesFR. The effect of neuromuscular training on the incidence of knee injury in female athletes: a prospective study. Am J Sports Med. 1999;27(6):699-706.
23.
HisawFLZarrowMX. The physiology of relaxin. Vitam Horm. 1950;8:151-178.
24.
HootmanJMDickRAgelJ. Epidemiology of collegiate injuries for 15 sports: summary and recommendations for injury prevention initiatives. J Athl Train. 2007;42(2):311-319.
25.
HsuSYNakabayashiKNishiS. Activation of orphan receptors by the hormone relaxin. Science. 2002;295(5555):671-674.
26.
KapilaSWangWUstonK. Matrix metalloproteinase induction by relaxin causes cartilage matrix degradation in target synovial joints. Ann N Y Acad Sci. 2009;1160:322-328.
27.
KapilaSXieYQ. Targeted induction of collagenase and stromelysin by relaxin in unprimed and β-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes. Lab Invest. 1998;78:925-938.
28.
Khan-DawoodFSGoldsmithLTWeissGDawoodMY. Human corpus luteum secretion of relaxin, oxytocin, and progesterone. J Clin Endocrinol Metabol. 1989;68(3):627-631.
29.
LeeWJChoiIKLeeJH. Relaxin-expressing adenovirus decreases collagen synthesis and up-regulates matrix metalloproteinase expression in keloid fibroblasts: in vitro experiments. Plast Reconstr Surg. 2012;130(3):407e-417e.
30.
LoudonJKJenkinsWLoudonKL. The relationship between static posture and ACL injury in female athletes. J Orthop Sports Phys Ther. 1996;24(2):91-97.
31.
MandelbaumBRSilversHJWatanabeDS. Effectiveness of a neuromuscular and proprioceptive training program in preventing anterior cruciate ligament injuries in female athletes: 2-year follow-up. Am J Sports Med. 2005;33(7):1003-1010.
32.
MartineauPAAl-JassirFLencznerEBurmanML. Effect of the oral contraceptive pill on ligamentous laxity. Clin J Sport Med. 2004;14(5):281-286.
33.
MaseelallPGardnerJWojtczukAWeissGGoldsmithLT. Relaxin receptor LGR7 (RXFP1) is regulated by estrogen. Ann N Y Acad Sci. 2009;1160:91-92.
34.
MastersonRHewitsonTDKelynackK. Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro. Nephrol Dial Transplant. 2004;19(3):544-552.
35.
MookerjeeIHewitsonTDHallsML. Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2. FASEB J. 2009;23(4):1219-1229.
36.
MosherWDJonesJ. Use of contraception in the United States: 1982-2008. Vital Health Stat 23. 2010;29:1-44.
37.
MyklebustGEngebretsenLBraekkenIHSkjølbergAOlsenOEBahrR. Prevention of anterior cruciate ligament injuries in female team handball players: a prospective intervention study over three seasons. Clin J Sport Med. 2003;13(2):71-78.
38.
NaqviTDuongTTHashemGShigaMZhangQKapilaS. Relaxin’s induction of metalloproteinases is associated with the loss of collagen and glycosaminoglycans in synovial joint fibrocartilaginous explants. Arthritis Res Ther. 2005;7(1):R1-R11.
39.
OsheroffPLCroninMJLofgrenJA. Relaxin binding in the rat heart atrium. Proc Natl Acad Sci U S A. 1992;89(6):2384-2388.
40.
PalejwalaSSteinDEWeissGMoniaBPTortorielloDGoldsmithLT. Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology. 2001;142(8):3405-3413.
41.
ParkSKStefanyshynDJLoitz-RamageBHartDARonskyJL. Changing hormone levels during the menstrual cycle affect knee laxity and stiffness in healthy female subjects. Am J Sports Med. 2009;37(3):588-598.
42.
PokornyMJSmithTDCalusSADennisonEA. Self-reported oral contraceptive use and peripheral joint laxity. J Orthop Sports Phys Ther. 2000;30(11):683-692.
43.
ProdromosCCHanYRogowskiJJoyceBShiK. A meta-analysis of the incidence of anterior cruciate ligament tears as a function of gender, sport, and a knee injury-reduction regimen. Arthroscopy. 2007;23(12):1320-1325.e6.
44.
Rahr-WagnerLThillemannTMMehnertFPedersenABLindM. Is the use of oral contraceptives associated with operatively treated anterior cruciate ligament injury? A case-control study from the Danish Knee Ligament Reconstruction Registry. Am J Sports Med. 2014;42(12):2897-2905.
RuedlGPlonerPLinortnerI. Are oral contraceptive use and menstrual cycle phase related to anterior cruciate ligament injury risk in female recreational skiers?Knee Surg Sports Traumatol Arthrosc. 2009;17(9):1065-1069.
47.
SamuelCSUnemoriENMookerjeeI. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology. 2004;145(9):4125-4133.
48.
SassoliCChelliniFPiniA. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling. PLoS One. 2013;8(5):e63896.
49.
ShelbourneKDDavisTJKlootwykTE. The relationship between intercondylar notch width of the femur and the incidence of anterior cruciate ligament tears: a prospective study. Am J Sports Med. 1998;26(3):402-408.
StevensonJHBeattieCSSchwartzJBBusconiBD. Assessing the effectiveness of neuromuscular training programs in reducing the incidence of anterior cruciate ligament injuries in female athletes: a systematic review. Am J Sports Med. 2015;43(2):482-490.
52.
SudoSKumagaiJNishiS. H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem. 2003;278(10):7855-7862.
53.
TakanoMYamaguchiMNakajimaRKojimaTKasaiK. Relaxin modulates collagen type I and matrix metalloproteinase-1 expression by human periodontal ligament cells. J Oral Biosci. 2008;50(4):222-229.
54.
UnemoriENAmentoEP. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem. 1990;265(18):10681-10685.
55.
UnemoriENPickfordLBSallesAL. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest. 1996;98(12):2739-2745.
56.
Weiss G.Relaxin. Annu Rev Physiol. 1984;46(24):43-52.
57.
WojtysEMHustonLJBoyntonMDSpindlerKPLindenfeldTN. The effect of the menstrual cycle on anterior cruciate ligament injuries in women as determined by hormone levels. Am J Sports Med. 2002;30(2):182-188.
58.
WoodhouseESchmaleGASimonianPTencerAHuberPSeidelK. Reproductive hormone effects on strength of the rat anterior cruciate ligament. Knee Surg Sports Traumatol Arthrosc. 2007;15(4):453-460.
